|
FY2024
12 months to Jun 30, 2024
|
|
|---|---|
| Cash from operating activities: | |
| Net loss | |
| Adjustments to net loss: | |
| Share in loss of jointly controlled entities | |
| Share based listing expenses | |
| Share based payment expense | |
| Depreciation and amortization expense | |
| Non-cash finance costs recognised in profit or loss | |
| Unrealised (gain)/loss on derivative financial instruments | |
| Deferred income tax expense/(benefit) | |
| Changes in operating assets and liabilities: | |
| Decrease/(Increase) in trade and other receivable | |
| (Increase)/decrease in prepayments | |
| (Increase)/decrease in tax incentive receivable | |
| Increase/(decrease) in trade and other payables | |
| Deferred income | |
| Increase/(decrease) in contract liabilities | |
| Increase in provisions | |
| Foreign exchange differences | |
| Cash flows from (used in) operating activities | |
| Cash flows from investing activities: | |
| Acquisition of interest in joint venture | |
| Interest received | |
| Loans and advances paid to related parties | |
| Purchases of property, plant and equipment | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Payment of deferred consideration | |
| Proceeds from borrowings and other financial liabilities | |
| Proceeds from Capital Reorganisation | |
| Increase/(decrease) in lease liabilities | |
| Net cash generated by financing activities | |
| Net increase/(decrease) in cash and cash equivalents | |
| Effect of exchange rate changes on cash | |
| Cash and cash equivalents at the beginning of the year | |
| Cash and cash equivalents at the end of the year |
Loading...
